CPT 81468 HLA Typing Reimbursement & Benchmarks | OpenPayer

Summary & Overview

CPT 81468: High-Resolution HLA Class I & II Typing, DNA Analysis

CPT code 81468 is a laboratory procedure for high-resolution Human Leukocyte Antigen (HLA) Class I and II typing, performed via DNA analysis for each locus. This advanced testing is crucial for organ and tissue transplantation, ensuring optimal donor-recipient compatibility and reducing the risk of rejection. Nationally, HLA typing is a cornerstone in transplant medicine, supporting clinical decisions for kidney, heart, lung, liver, and other transplants.

This publication provides a comprehensive overview of CPT code 81468, including its clinical significance, laboratory service context, and typical site of service. Readers will gain insights into payer coverage, with a focus on Blue Cross Blue Shield, and understand how this code fits within broader laboratory and pathology billing practices. The summary also highlights related codes for HLA typing at different resolution levels and unlisted molecular pathology procedures, offering context for coding and reimbursement.

Key benchmarks, policy updates, and clinical applications are discussed to inform stakeholders about current trends and requirements in HLA typing. The publication is designed for healthcare professionals, laboratory administrators, and policy analysts seeking clarity on coding, coverage, and the evolving landscape of transplant-related laboratory services.

Blue Cross Blue ShieldCPT 81468HLA typingLaboratory servicesTransplant medicinePathologyClinical geneticsBilling and codingHigh resolutionOrgan transplantationIndependent laboratory

CPT Code Overview

CPT code 81468 represents high-resolution typing of Human Leukocyte Antigen (HLA) Class I and II alleles, such as HLA-A, -B, -C, -DRB1, and -DQB1, using DNA analysis for each locus. This laboratory service is essential for determining precise HLA compatibility, which plays a critical role in organ and tissue transplantation. The typical site of service for this procedure is an independent laboratory, designated as Place of Service 81. High-resolution HLA typing provides detailed genetic information that supports clinical decision-making in transplant medicine and immunology.

Clinical & Coding Specifications

Clinical Context

A patient with a history of organ transplantation, such as kidney, heart, lung, or liver, is being evaluated for ongoing transplant management or potential re-transplantation. The clinical workflow involves ordering high-resolution HLA Class I and II typing to determine compatibility between the patient and a potential donor. The laboratory receives a blood sample, performs DNA-based testing to identify specific HLA alleles at loci such as HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1. Results are used by the clinical team to assess immunologic risk and guide transplant decisions. This service is typically performed in an independent laboratory setting (Place of Service 81).

Coding Specifications

Modifier 26: Indicates the professional component of the laboratory service, typically used when a physician interprets the results but does not perform the technical work.
Modifier TC: Indicates the technical component, used when the laboratory performs the actual testing but does not interpret the results.

Taxonomy Code	Specialty Name
`207ZP0102X`

National Reimbursement Benchmarks

For CPT code 81468, the national mean rate for Blue Cross Blue Shield and BUCA (average commercial) is $80.02. No Medicare benchmark data is available for this code. The mean rates for both commercial payers are identical, indicating uniformity in national pricing.

Rate dispersion is minimal across both Blue Cross Blue Shield and BUCA, with the 25th, 50th, and 75th percentiles all at $80.00. This suggests a very tight distribution, with no significant variation in rates among providers nationally for these payers.

The table and chart below present the full breakdown of national benchmarks for CPT code 81468 by payer.

81447 – Targeted genomic sequence analysis panel, solid organ neoplasm, DNA analysis, 5-50 genes

81455-SOLID-ORGAN-OR-HEMATOLYMPHOID-NEOPLASM-OR-DISORDER-51-OR

81455 – Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed

81416-CYP2C19-CYTOCHROME-P450-FAMILY-2-SUBFAMILY-C-POLYPEPTIDE-19

81416 – CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) (e.g., drug metabolism), gene analysis, common variants (e.g., *2, *3, *4, *5, *6, *7, *8, *17)

81469-HEREDITARY-BREAST-CANCERRELATED-DISORDERS-EG-HEREDITARY

81469 – Hereditary breast cancer-related disorders (e.g., hereditary breast and ovarian cancer, hereditary breast cancer-related disorders), genomic sequence analysis panel, must include sequencing of at least 14 genes (e.g., ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, STK11, and TP53)

81456-GENOMIC-SEQUENCE-ANALYSIS-PANEL-EG-TUMOR-OR-BONE-MARROW-RNA

81456 – Genomic sequence analysis panel (e.g., tumor or bone marrow), RNA alterations, 51 or more genes

81410-GENOMIC-SEQUENCING-PROCEDURE-HERITABLE-THORACIC-AORTIC

CPT 81410: Genomic Sequencing for Heritable Thoracic Aortic Disease

81408-TIER-2-MOLECULAR-PATHOLOGY-PROCEDURES-LEVEL

CPT 81408: Advanced Molecular Pathology Laboratory Procedure

81477-MOLECULAR-PATHOLOGY-PROCEDURE-LEVEL-9-EG-ANALYSIS-OF-1125

CPT 81477: Molecular Pathology Procedure, Level 9 DNA Sequence Analysis

81429-GENOMIC-SEQUENCE-ANALYSIS-PANEL-SOLID-ORGAN-NEOPLASM-DNA

CPT 81429: Genomic Sequence Analysis Panel for Solid Organ Neoplasms

81476-CYP2C9-CYTOCHROME-P450-FAMILY-2-SUBFAMILY-C-POLYPEPTIDE-9

CPT 81476: CYP2C9 Gene Analysis for Drug Metabolism